TP53BP2 and neoplasm: Activation of RAS can stimulate apoptosis-stimulating protein of p53 2 (ASPP2) and β-catenin to translocate from the cell junction to the cytoplasm and nucleus, reducing the formation of ASPP2-β-catenin complex, leading to EMT of tumor cells (79).